LAURA BLINN: Open Payments
NPI 1134369127 · PITTSBURGH, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$427 in 17 payments from 7 companies in 2025. Trend: 2023 $93 · 2024 $289 · 2025 $427
Food & beverage: $347Education: $80
| Company | Payments | Amount |
|---|---|---|
| Cumberland Pharmaceuticals, Inc. | 5 | $120 |
| Astellas Pharma US Inc | 2 | $100 |
| ABBVIE INC. | 4 | $81 |
| Merck Sharp & Dohme LLC | 3 | $53 |
| Melinta Therapeutics, LLC | 1 | $31 |
| Invivyd Inc | 1 | $22 |
| Ferring Pharmaceuticals Inc. | 1 | $20 |
Products named: VIBATIV, EMBLAVEO, Rezzayo, DALVANCE, PEMGARDA, PREVYMIS, REBYOTA, Cresemba.
Industry payments across PA — which companies pay providers there.
